NHC
MDT icon

Nicholas Hoffman & Company’s Medtronic MDT Stock Holding History

Nicholas Hoffman & Company’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
19,853
+4,303
+28% +$347K 0.03% 109
2026
Q1 		$1.35M Sell
15,550
-37
-0.2% -$3.54K 0.03% 113
2025
Q4 		$1.5M Sell
15,587
-237
-1% -$23K 0.03% 106
2025
Q3 		$1.51M Buy
15,824
+160
+1% +$14.7K 0.04% 102
2025
Q2 		$1.37M Sell
15,664
-20
-0.1% -$1.7K 0.04% 105
2025
Q1 		$1.41M Sell
15,684
-100
-0.6% -$8.95K 0.05% 96
2024
Q4 		$1.26M Buy
15,784
+17
+0.1% +$1.47K 0.05% 101
2024
Q3 		$1.42M Sell
15,767
-6
-0% -$505 0.06% 99
2024
Q2 		$1.24M Buy
15,773
+95
+0.6% +$7.79K 0.06% 102
2024
Q1 		$1.37M Sell
15,678
-436
-3% -$37.2K 0.07% 92
2023
Q4 		$1.33M Buy
16,114
+2,275
+16% +$173K 0.08% 91
2023
Q3 		$1.08M Sell
13,839
-169
-1% -$14.1K 0.08% 101
2023
Q2 		$1.23M Sell
14,008
-1,103
-7% -$95K 0.05% 94
2023
Q1 		$1.22M Buy
15,111
+735
+5% +$59.9K 0.11% 95
2022
Q4 		$1.12M Buy
14,376
+10,869
+310% +$881K 0.12% 106
2022
Q3 		$283K Buy
3,507
+116
+3% +$10.4K 0.01% 205
2022
Q2 		$304K Sell
3,391
-896
-21% -$90.8K 0.01% 204
2022
Q1 		$476K Hold
4,287
– – 0.02% 173
2021
Q4 		$443K Sell
4,287
-2
-0% -$232 0.01% 180
2021
Q3 		$538K Sell
4,289
-339
-7% -$43.9K 0.09% 150
2021
Q2 		$574K Sell
4,628
-4,494
-49% -$564K 0.1% 146
2021
Q1 		$1.08M Buy
9,122
+1,963
+27% +$230K 0.22% 93
2020
Q4 		$839K Sell
7,159
-22
-0.3% -$2.42K 0.19% 97
2020
Q3 		$746K Sell
7,181
-62
-0.9% -$6.23K 0.2% 97
2020
Q2 		$664K Sell
7,243
-435
-6% -$41.7K 0.19% 103
2020
Q1 		$692K Buy
7,678
+38
+0.5% +$4.04K 0.23% 91
2019
Q4 		$867K Sell
7,640
-89
-1% -$9.77K 0.24% 90
2019
Q3 		$840K Sell
7,729
-5,157
-40% -$538K 0.26% 89
2019
Q2 		$1.25M Sell
12,886
-298
-2% -$27.2K 0.39% 61
2019
Q1 		$1.2M Sell
13,184
-37
-0.3% -$3.31K 0.39% 63
2018
Q4 		$1.2M Sell
13,221
-152
-1% -$14.2K 0.41% 55
2018
Q3 		$1.32M Sell
13,373
-100
-0.7% -$9.24K 0.44% 51
2018
Q2 		$1.15M Sell
13,473
-60
-0.4% -$5.01K 0.42% 59
2018
Q1 		$1.09M Buy
13,533
+76
+0.6% +$6.27K 0.42% 62
2017
Q4 		$1.09M Sell
13,457
-410
-3% -$32.8K 0.43% 60
2017
Q3 		$1.08M Buy
13,867
+30
+0.2% +$2.49K 0.45% 60
2017
Q2 		$1.23M Buy
13,837
+215
+2% +$18.1K 0.56% 50
2017
Q1 		$1.1M Buy
13,622
+1,470
+12% +$115K 0.51% 56
2016
Q4 		$858K Sell
12,152
-1,163
-9% -$91.4K 0.43% 62
2016
Q3 		$1.15M Sell
13,315
-285
-2% -$24.8K 0.63% 41
2016
Q2 		$1.18M Buy
+13,600
New +$1.1M 0.68% 33

Other funds holding MDT

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
GAM
Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Nicholas Hoffman & Company's MDT Position: Q2 2026 in Review

Nicholas Hoffman & Company increased its Medtronic (MDT) stake by 28% in Q2 2026, buying an estimated $347K and bringing the position to 19,853 shares worth $1.55M. The position accounts for 0.03% of the portfolio, ranked #109.

Nicholas Hoffman & Company first reported a position in MDT in Q2 2016 and has held it in 41 quarters since. 1,077 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Nicholas Hoffman & Company held 19,853 shares of Medtronic worth $1.55M as of Q2 2026.
  • Nicholas Hoffman & Company bought 4,303 Medtronic shares in Q2 2026, an estimated $347K.
  • Medtronic made up 0.03% of Nicholas Hoffman & Company's portfolio in Q2 2026, its #109 holding.
  • Nicholas Hoffman & Company first reported a position in Medtronic in Q2 2016 and has held it in 41 quarters since.
  • 1,077 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Nicholas Hoffman & Company's 13F filing for Q2 2026, filed 4 Aug 2026.